BioRestorative Therapies Named One of Ten Most Innovative Regenerative Medicine Companies in 2022 by Insights Care Magazine
January 26, 2022 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
BioRestorative Therapies, Inc. Releases Year-End Message
December 20, 2021 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Dec. 20, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...
North America $1.4 Billion Organoids Market to 2027 - Emergence of Three-dimensional (3-D) Organoids
March 16, 2021 05:28 ET
|
Research and Markets
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "North America Organoids Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Application, and Source, and Country" report has been...
Global Organoids Market Report 2021: Increasing Adoption of Personalized Drugs to Drive Organoids Market - Forecast to 2027
March 16, 2021 05:23 ET
|
Research and Markets
Dublin, March 16, 2021 (GLOBE NEWSWIRE) -- The "Organoids Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type; Application; Source, and Geography" report has been added to...
India $470 Million Stem Cell Market Competition Forecast & Opportunities, 2021-2026
February 16, 2021 04:18 ET
|
Research and Markets
Dublin, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The "India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery...
Global Mesenchymal Stem Cells (MSC) Market Strategic Report 2021: Profiles & Activities of the Leading 98 MSC Companies
February 11, 2021 05:23 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Mesenchymal Stem Cells - Advances and Applications, 2021" report has been added to ResearchAndMarkets.com's offering. Mesenchymal stem cells (MSCs)...
India Stem Cell Markets, Competition Forecast & Opportunities, 2026
November 24, 2020 04:53 ET
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery...
Mesoblast Reports 2015 Financial Year Results And Provides Update On Phase 3 Chronic Heart Failure Program
August 16, 2015 20:28 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 16, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported its 2015 full financial year results, and provided an update on important...
American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
July 02, 2014 08:30 ET
|
American CryoStem Corp.
EATONTOWN, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
June 18, 2014 09:00 ET
|
American CryoStem Corp.
EATONTOWN, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...